drugset
drugset / Trial / NCT02262754

PF-06372865 In Subjects With Chronic Low Back Pain

NCT02262754 ↗

Phase 2 Completed 302 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

PF-06372865 In Subjects With Chronic Low Back Pain

Timeline

Start
2014-10
Primary completion
2015-08
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Darigabat Small molecule — —
Comparator Naproxen Small molecule 500 mg —

Indications

chronic pain syndrome